PDK1 and pancreatic neoplasm: Specifically, miRNA-375 targets directly PDK1 and miRNA-200c targets MUC4 (Mucin 4), influencing epithelial–mesenchymal transition and metastatic potential in pancreatic cancer cells [53,54].